FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. Share Price

Certificat

DE000MC74YT1

Market Closed - Bid/Ask 09:31:54 20/06/2024 pm IST After market 12:10:24 am
0.72 EUR +9.09% Intraday chart for FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. 0.765 +6.25%
Current month+1.54%
1 month-10.81%
Date Price Change
20/24/20 0.72 +9.09%
19/24/19 0.66 -4.35%
18/24/18 0.69 +2.99%
17/24/17 0.67 -2.90%
14/24/14 0.69 +4.55%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 09:31 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MC74YT
ISINDE000MC74YT1
Date issued 16/03/2020
Strike 187 $
Maturity Unlimited
Parity 63.51 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.69
Lowest since issue 0.57
Spread 0.01
Spread %1.30%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus